Filing Details

Accession Number:
0001209191-10-006944
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-02-04 12:00:00
Reporting Period:
2010-02-03
Filing Date:
2010-02-04
Accepted Time:
2010-02-04 16:48:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
59478 Lilly Eli & Co LLY Pharmaceutical Preparations (2834) 350470950
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1359067 W Derica Rice Lilly Corporate Center
Indianapolis IN 46285
Evp-Global Services And Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-02-03 2,100 $35.22 24,943 No 4 S Direct
Common Stock Disposition 2010-02-03 100 $35.23 24,843 No 4 S Direct
Common Stock Disposition 2010-02-03 3,000 $35.20 21,843 No 4 S Direct
Common Stock Disposition 2010-02-03 300 $35.16 21,543 No 4 S Direct
Common Stock Disposition 2010-02-03 700 $35.15 20,843 No 4 S Direct
Common Stock Disposition 2010-02-03 100 $35.33 20,743 No 4 S Direct
Common Stock Disposition 2010-02-03 400 $35.32 20,343 No 4 S Direct
Common Stock Disposition 2010-02-03 400 $35.34 19,943 No 4 S Direct
Common Stock Disposition 2010-02-03 100 $35.35 19,843 No 4 S Direct
Common Stock Disposition 2010-02-03 1,000 $35.31 18,843 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 4,920 Indirect 401(k)
Common Stock 1,454 Indirect 401(k) - by wife
Common Stock 54,130 Indirect by wife
Footnotes
  1. Reporting person disclaims beneficial ownership of these shares.